Robot dog brings joy to kids battling blood cancer

NCT ID NCT07607379

Not yet recruiting Symptom relief Sponsor: Koç University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a robotic dog named AIBO can improve emotional well-being and quality of life in children aged 8-15 with blood cancers who are undergoing a stem cell transplant. The children will interact with AIBO while isolated in the hospital for about 30 days. Researchers will measure changes in mood, emotional health, and overall quality of life using standard questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AIBO robotic dog
What this could lead to: If it works, this could offer a safe, non-drug way to reduce anxiety and loneliness in hospitalized children with cancer.
What could go wrong: This is a very small, early-stage study with only 28 participants. The robotic dog is not a treatment for the cancer itself, and results may not apply to all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EMOTIONAL WELL-BEING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EMOTIONAL WELL-BEING PEDIATRIC ONCOLOGY QUALITY OF LIFE

More trials for these conditions

Other studies related to the condition(s) this trial covers.